Literature DB >> 24242737

Advanced glycation end products, aortic stiffness, and wave reflection in peritoneal dialysis as compared to hemodialysis.

Fabrice Mac-Way1, Véronique Couture, Mihai S Utescu, Sophie Ignace, Sacha A De Serres, Renée-Claude Loignon, Karine Marquis, Richard Larivière, Mohsen Agharazii.   

Abstract

BACKGROUND: Modification of vascular extracellular matrix by advanced glycation end products (AGEs) may result in vascular stiffness. Because of higher exposure to glucose, we hypothesized that patients on peritoneal dialysis (PD) may have higher tissue levels of AGEs, increased vascular stiffness, and enhanced central augmentation pressure as compared to hemodialysis patients (HD).
METHODS: In a cross-sectional study, 43 PD were matched to 43 HD based on age, gender, diabetes, and dialysis vintage. Tissue levels of AGEs were assessed by skin autofluorescence (skin AF). Aortic stiffness was measured by carotid-femoral pulse wave velocity (cf-PWV), and heart rate-adjusted augmentation pressure (AP@75) was performed by arterial tonometry.
RESULTS: Baseline characteristics were similar in both groups except for lower prevalence of cardiovascular disease (CVD) and higher exposure to smoking in PD. Skin AF and cf-PWV were not statistically different, but PD patients had a lower AP@75 (P = 0.023). However, after adjustments for prevalence of CVD and smoking status, skin AF was higher in PD by 0.587 AU (95 % CI 0.091-1.215, P = 0.020), and cf-PWV was higher in PD by 2.20 m/s (95 % CI 0.56-3.84, P = 0.009), while AP@75 was not different. Overall, there was a significant association between skin AF and cf-PWV and AP@75.
CONCLUSION: Skin AF and aortic stiffness were higher in PD after adjustments for imbalances in baseline characteristics. Independent of dialysis modality, there was a positive association between skin AF, aortic stiffness, and enhanced wave reflection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24242737     DOI: 10.1007/s11255-013-0597-6

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  39 in total

1.  Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.

Authors:  A P Guerin; J Blacher; B Pannier; S J Marchais; M E Safar; G M London
Journal:  Circulation       Date:  2001-02-20       Impact factor: 29.690

2.  Comparison of the oscillometric blood pressure monitor (BPM-100(Beta) ) with the auscultatory mercury sphygmomanometer.

Authors:  G S Mattu; T L Perry; J M Wright
Journal:  Blood Press Monit       Date:  2001-06       Impact factor: 1.444

3.  Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies.

Authors:  R Asmar; A Benetos; J Topouchian; P Laurent; B Pannier; A M Brisac; R Target; B I Levy
Journal:  Hypertension       Date:  1995-09       Impact factor: 10.190

4.  Skin autofluorescence is associated with renal function and cardiovascular diseases in pre-dialysis chronic kidney disease patients.

Authors:  Kenichi Tanaka; Yoshihiro Tani; Jun Asai; Fumihiko Nemoto; Yuki Kusano; Hodaka Suzuki; Yoshimitsu Hayashi; Koichi Asahi; Tetsuo Katoh; Toshio Miyata; Tsuyoshi Watanabe
Journal:  Nephrol Dial Transplant       Date:  2010-06-29       Impact factor: 5.992

5.  Association of insulin resistance with arterial stiffness in nondiabetic peritoneal dialysis patients.

Authors:  Erhan Tatar; Meltem Sezis Demirci; Fatih Kircelli; Ozkan Gungor; Mehmet Nuri Turan; Ebru Sevinc Ok; Gulay Asci; Mehmet Ozkahya; Ercan Ok
Journal:  Int Urol Nephrol       Date:  2011-06-04       Impact factor: 2.370

6.  Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study.

Authors:  Francis Verbeke; Wim Van Biesen; Eero Honkanen; Björn Wikström; Per Bruno Jensen; Jean-Marie Krzesinski; Merete Rasmussen; Raymond Vanholder; Pieter L Rensma
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-09       Impact factor: 8.237

7.  Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients.

Authors:  Jaime Uribarri; Melpomeni Peppa; Weijing Cai; Teresia Goldberg; Min Lu; Cijiang He; Helen Vlassara
Journal:  J Am Soc Nephrol       Date:  2003-03       Impact factor: 10.121

8.  Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

Authors:  M P Wautier; O Chappey; S Corda; D M Stern; A M Schmidt; J L Wautier
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-05       Impact factor: 4.310

9.  Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.

Authors:  Siska Mortier; Dirk Faict; Casper G Schalkwijk; Norbert H Lameire; An S De Vriese
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

10.  Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease.

Authors:  Irena Makulska; Maria Szczepańska; Dorota Drożdż; Dorota Polak-Jonkisz; Danuta Zwolińska
Journal:  Pediatr Nephrol       Date:  2012-09-15       Impact factor: 3.714

View more
  5 in total

Review 1.  Arterial stiffness and increased cardiovascular risk in chronic kidney disease.

Authors:  Yuxia Ma; Lin Zhou; Jinghui Dong; Xiaoshen Zhang; Shi Yan
Journal:  Int Urol Nephrol       Date:  2015-05-20       Impact factor: 2.370

2.  Higher skin autofluorescence detection using AGE-Reader™ technology as a measure of increased tissue accumulation of advanced glycation end products in dialysis patients with diabetes: a meta-analysis.

Authors:  Seshadri Reddy Varikasuvu; Sowjanya Aloori; Aparna Varma Bhongir
Journal:  J Artif Organs       Date:  2020-07-01       Impact factor: 1.731

3.  Serum biomarkers, skin autofluorescence and other methods. Which parameter better illustrates the relationship between advanced glycation end products and arterial stiffness in the general population?

Authors:  Július Gelžinský; Otto Mayer; Jitka Seidlerová; Markéta Mateřánková; Štěpán Mareš; Veronika Kordíkova; Ladislav Trefil; Renata Cífková; Jan Filipovský
Journal:  Hypertens Res       Date:  2021-01-12       Impact factor: 3.872

4.  An association of cognitive impairment with diabetes and retinopathy in end stage renal disease patients under peritoneal dialysis.

Authors:  Jin-Lan Liao; Zu-Ying Xiong; Zhi-Kai Yang; Li Hao; Gui-Ling Liu; Ye-Ping Ren; Qin Wang; Li-Ping Duan; Zhao-Xia Zheng; Jie Dong
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

5.  Skin Autofluorescence and Mortality in Patients on Peritoneal Dialysis.

Authors:  Emília Mácsai; Attila Benke; István Kiss
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.